Biocryst Pharmaceuticals buy Evercore ISI
Start price
20.04.23
/
50%
€6.67
Target price
20.04.24
€9.11
Performance (%)
-38.50%
End price
21.04.24
€4.10
Summary
This prediction ended on 21.04.24 with a price of €4.10. The BUY prediction by Evercore_ISI for Biocryst Pharmaceuticals performed very badly with a performance of -38.50%. Evercore_ISI has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Biocryst Pharmaceuticals | 3.907% | 3.907% | -7.282% |
iShares Core DAX® | 1.395% | -0.696% | 15.472% |
iShares Nasdaq 100 | 2.287% | 7.501% | 34.748% |
iShares Nikkei 225® | 1.617% | 2.769% | 11.442% |
iShares S&P 500 | 0.659% | 4.280% | 26.778% |
Comments by Evercore_ISI for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target lowered by analysts at Evercore ISI from $13.00 to $10.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten